Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Nucleic Acids Res. 2019 Jan 25;47(2):e7. doi: 10.1093/nar/gky888.
Alternative pre-mRNA splicing generates functionally distinct transcripts from the same gene and is involved in the control of multiple cellular processes, with its dysregulation being associated with a variety of pathologies. The advent of next-generation sequencing has enabled global studies of alternative splicing in different physiological and disease contexts. However, current bioinformatics tools for alternative splicing analysis from RNA-seq data are not user-friendly, disregard available exon-exon junction quantification or have limited downstream analysis features. To overcome such limitations, we have developed psichomics, an R package with an intuitive graphical interface for alternative splicing quantification and downstream dimensionality reduction, differential splicing and gene expression and survival analyses based on The Cancer Genome Atlas, the Genotype-Tissue Expression project, the Sequence Read Archive project and user-provided data. These integrative analyses can also incorporate clinical and molecular sample-associated features. We successfully used psichomics in a laptop to reveal alternative splicing signatures specific to stage I breast cancer and associated novel putative prognostic factors.
可变剪接从同一个基因生成具有不同功能的转录本,并参与多种细胞过程的调控,其失调与多种病理有关。下一代测序的出现使得在不同的生理和疾病环境中对可变剪接进行全局研究成为可能。然而,目前基于 RNA-seq 数据的可变剪接分析的生物信息学工具并不友好,忽略了可用的外显子-外显子连接定量,或者具有有限的下游分析功能。为了克服这些限制,我们开发了 psichomics,这是一个 R 包,具有直观的图形界面,用于可变剪接定量和下游降维、差异剪接和基因表达以及基于癌症基因组图谱、组织表达项目、序列读取档案项目和用户提供的数据的生存分析。这些综合分析还可以包含临床和分子样本相关特征。我们成功地在笔记本电脑上使用 psichomics 揭示了特定于 I 期乳腺癌的可变剪接特征,并发现了新的潜在预后因素。